Delivra Health Brands Engages Generation for Market Making Services
Delivra Health Brands Engages Generation for Market Making Services
Vancouver, British Columbia--(Newsfile Corp. - July 5, 2023) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, announced today that subject to regulatory approval, it has retained Generation IACP Inc. ("Generation"), commencing July 4, 2023, to provide trading, market stabilization and liquidity services for the Company in compliance with the policies and guidelines of the TSX Venture Exchange (the "TSX-V") and applicable legislation. Generation will trade the common shares of Delivra Health (the "Shares") on the TSX-V for the purposes of maintaining a reasonable market and improving the liquidity of the Shares.
溫哥華，不列顛哥倫比亞省-(Newsfile Corp.-2023年7月5日)-Delivra Health Brands Inc.(TSXV：DHB)(OTCQB：DHBUF)(“Delivra Health“或”公司)，一家在健康和健康領域獨樹一幟的消費品包裝公司，今天宣佈，如果獲得監管部門的批准，它將保留Generation IACP Inc.(世代)，自2023年7月4日起，根據多倫多證券交易所創業板(The TSX Venture Exchange)的政策和指引，為本公司提供交易、市場穩定和流動性服務多倫多證券交易所-V“)和適用的立法。世代將交易Delivra Health的普通股(”股票“)於多倫多證交所-V上市，以維持一個合理的市場及改善股份的流動資金。
Under the issuer trading services agreement between Generation and the Company (the "Generation Agreement"), the Company has agreed to pay Generation a fee of C$7,500 per month, plus applicable taxes and subject to an annual increase of 3% commencing on the second anniversary of the Generation Agreement (the "Generation Fee"). The Generation Fee will be payable quarterly in advance. The initial term of the Generation Agreement will commence on July 5, 2023 and last for six months, and such term will be automatically renewed for a subsequent six month period unless terminated earlier by 30 days' prior written notice by the Company to Generation. Generation will also have the right to terminate the Generation Agreement at any time upon prior written notice to the Company.
根據GENERATION與本公司的發行人交易服務協定(“發電協定“)，本公司已同意向Generation支付每月7,500加元的費用，外加適用的稅項，並自發電協定(發電費“)。發電費用將按季預繳。發電協定的初始期限將於2023年7月5日開始，為期六個月，除非本公司提前30天書面通知發電公司終止，否則該期限將自動續期六個月。發電公司亦有權在事先書面通知本公司後隨時終止發電協定。
No stock options are being granted and no compensation other than as stated above is payable in connection with the engagement. Generation and the Company are unrelated and unaffiliated entities and at the time of the Generation Agreement, neither Generation nor its principals have an interest, directly or indirectly, in the securities of the Company. Generation will be responsible for the costs it incurs in buying and selling the Company's Shares, and no third party will be providing funds or securities for the market making activities. Generation, established in 1998, is a Toronto-based, independently owned, investment dealer providing innovative solutions for institutional, corporate and individual clients in Canada and abroad.
除上文所述外，不授予任何股票期權，也不支付與聘用有關的其他賠償。發電及本公司為無關連及無關聯實體，於訂立發電協定時，發電及其委託人概無直接或間接於本公司證券中擁有權益。世代將對買賣本公司股票所產生的成本負責，任何第三方都不會為做市活動提供資金或證券。世代成立於1998年，是一家總部位於多倫多的獨立擁有的投資交易商，為加拿大國內外的機構、公司和個人客戶提供創新的解決方案。
About Delivra Health Brands Inc.
關於Delivra Health Brands Inc.
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water and LivRelief, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water and LivReliefTM. For more information, please visit .
幫助人們通過替代健康解決方案控制自己的健康是Delivra Health團隊的動力所在！Delivra Health產品組合以夢幻水和LivRelipment等創新品牌為特色，這些品牌可以緩解慢性疼痛、焦慮和失眠等常見的日常問題。Delivra保健產品讓數百萬客戶重新獲得了他們的機動性、能量和生活品質。該公司的兩個子公司的網站是夢想之水和生活救濟TM。欲瞭解更多資訊，請訪問。
Cautionary Note Regarding Forward-Looking Statements
有關前瞻性陳述的注意事項
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to regulatory approval of the transactions contemplated by the Generation Agreement, and the ultimate term of the services to be provided by Generation.
本新聞稿包含適用於加拿大證券法的“前瞻性資訊”和“前瞻性陳述”(統稱為“前瞻性陳述”)。除有關歷史事實的陳述外，所有陳述均為前瞻性陳述，均基於截至本新聞稿發佈之日的預期、估計和預測。任何涉及關於預測、期望、信念、計劃、預測、目標、假設、未來事件或業績的討論的陳述(經常但不總是使用諸如“預期”或“不預期”、“預計”、“預期”或“不預期”、“計劃”、“預算”、“預定”、“預測”、“估計”、“相信”或“打算”或這些詞語和短語的變體，或陳述某些行動、事件或結果“可能”或“可能”、“將”，“可能”或“將”被視為發生或實現)不是歷史事實的陳述，可能是前瞻性陳述。在本新聞稿中，前瞻性陳述包括與發電協定預期的交易的監管批准有關的陳述，以及發電公司將提供的服務的最終期限。
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
這些前瞻性陳述是基於作出這些陳述時公司管理層的合理假設和估計。由於前瞻性陳述涉及已知和未知的風險、不確定因素和其他因素，可能導致公司的實際結果、業績或成就與此類前瞻性陳述明示或暗示的未來結果、業績或成就大不相同，因此未來的實際結果可能大不相同。這些因素包括：總體宏觀經濟狀況的波動；證券市場的波動；對公司經營市場規模的預期；消費者習慣的變化；公司成功實現其業務目標的能力；擴張計劃；政治和社會不確定因素；無法獲得足夠的保險來承保風險和危險；員工關係以及可能對公司經營市場的產品種植、生產、分銷和銷售施加限制的法律法規的存在。儘管本新聞稿中包含的前瞻性陳述是基於公司管理層認為或當時被認為是合理假設的，但公司不能向股東保證實際結果將與這些前瞻性陳述一致，因為可能存在其他因素導致結果與預期、估計或預期的結果不一致。讀者不應過分依賴本新聞稿中包含的前瞻性陳述和資訊。除非法律要求，否則公司不承擔更新關於信念、意見、預測或其他因素的前瞻性陳述的義務。
Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated March 2, 2021, and under the heading "Risks and Uncertainties" in the Company's management's discussion and analysis dated May 23, 2023, for the three and nine months ended March 31, 2023, filed under the Company's profile on SEDAR at .
有關這一風險和與公司業務有關的其他風險和不確定因素的更多資訊，載於公司日期為2021年3月2日的公司年度資訊表中的“風險因素”標題，以及公司管理層於2023年5月23日提交的截至2023年3月31日的三個月和九個月的管理討論和分析中的“風險和不確定因素”標題下。
Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.
多倫多證券交易所及其監管服務提供商(該術語在多倫多證券交易所-V的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。
Investor Relations:
Jack Tasse
Chief Financial Officer
IR@delivrahealth.com
1-877-915-7934
投資者關係：
傑克·塔斯
首席財務官
郵箱：ir@delivraHealth.com
電話：1-877-915-7934
53520377.3
53520377.3
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。